DKC1 and neoplasm: A possible explanation arises from in vitro experiments, in which loss of DKC1 function affect telomerase activity by reducing TERC levels and therefore leading to premature telomere shortening [17,18] that may result in chromosomal end-to-end fusions, breakage and rearrangements associated to tumor development [13,19].